Anna Edney discussed issues raised at the House Energy and Commerce Committee hearing on the 2012 meningitis outbreak that killed 32 people from contaminated drugs supplied by a Massachusetts-based compounding pharmacy. Several of the legislators asked pointed questions about the role of the Food and Drug Administration (FDA) in the oversight of compounding pharmacies. Topics included statistics surrounding the outbreak, and Republican and Democratic reactions to steps taken by the FDA. Ms. Edney also responded to telephone calls and electronic communications.